CAVALIER JASON (Chief Financial Officer) sold 0.1% of their position (684.00 shares) of LYRA THERAPEUTICS, INC. on the open market
Open‑market sale worth $6.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/14/2025ACC: 0000950170-25-095681
Officer· Chief Financial Officer
Since Sep 2021
-684.00
Net shares
Net seller
$6.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
684.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−684.00
Price / share
$8.91
Trade value
$6.09K
% of position
0.1%
7/10/2025
520K→519.32K
Total
Net shares
−684.00
Net value
-$6.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/10/2025 | S · Sale | −684.00 | $8.91 | $6.09K | 0.1% | 520K | 519.32K |
| Total | −684.00 | -$6.09K | ||||||
Derivative Transactions0
No derivative transactions reported